Statins reduce risk of progression to cirrhosis in people with HIV/HCV co-infection
HIV not a risk factor for fibrosis progression in people with hepatitis C
Hepatitis C antigen testing could eliminate need for two-step HCV testing, reduce cost of access
WHO issues new hepatitis C guidelines, EASL guidelines update forthcoming in September
